[go: up one dir, main page]

TR200002288T2 - Zotepin içeren sıvı farmasötik formülasyon - Google Patents

Zotepin içeren sıvı farmasötik formülasyon

Info

Publication number
TR200002288T2
TR200002288T2 TR2000/02288T TR200002288T TR200002288T2 TR 200002288 T2 TR200002288 T2 TR 200002288T2 TR 2000/02288 T TR2000/02288 T TR 2000/02288T TR 200002288 T TR200002288 T TR 200002288T TR 200002288 T2 TR200002288 T2 TR 200002288T2
Authority
TR
Turkey
Prior art keywords
acid
liquid pharmaceutical
zotepine
pharmaceutical formulation
formulation containing
Prior art date
Application number
TR2000/02288T
Other languages
English (en)
Inventor
Margaret Dyer Ann
Smith Alan
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of TR200002288T2 publication Critical patent/TR200002288T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

a) Agirlik/hacim olarak %2-7 arasindaki bir oranda Zotepin agirlik/hacim olarak %0.5-35 arasindaki bir oranda askorbik asit, fumarik asit, glütarik asit, laktik asit, malik asit, sorbik asit ve tartarik asidi içeren bir gruptan seçilen organik bir asidi, c) hacim/hacim olarak %15-60 arasindaki bir oranda etanol ve d) % 100'e tamamlayacak kadar olan bir oranda bir sivi seyreltici içerebilen, damla kullanilabilen veya içecek ieçinde kullanilabilen sivi bir farmasötik.
TR2000/02288T 1998-02-07 1999-01-27 Zotepin içeren sıvı farmasötik formülasyon TR200002288T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9802617.2A GB9802617D0 (en) 1998-02-07 1998-02-07 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
TR200002288T2 true TR200002288T2 (tr) 2000-12-21

Family

ID=10826622

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02288T TR200002288T2 (tr) 1998-02-07 1999-01-27 Zotepin içeren sıvı farmasötik formülasyon

Country Status (24)

Country Link
US (1) US6239165B1 (tr)
EP (1) EP1054666B1 (tr)
JP (1) JP2002502818A (tr)
KR (1) KR20010040717A (tr)
AR (1) AR018062A1 (tr)
AT (1) ATE227988T1 (tr)
AU (1) AU2720099A (tr)
BG (1) BG104682A (tr)
BR (1) BR9907644A (tr)
CA (1) CA2320475A1 (tr)
CO (1) CO4970815A1 (tr)
CZ (1) CZ291975B6 (tr)
DE (1) DE69904021T2 (tr)
DK (1) DK1054666T3 (tr)
ES (1) ES2188135T3 (tr)
GB (1) GB9802617D0 (tr)
HR (1) HRP20000579A2 (tr)
HU (1) HUP0100769A3 (tr)
PL (1) PL342213A1 (tr)
PT (1) PT1054666E (tr)
SK (1) SK11472000A3 (tr)
TR (1) TR200002288T2 (tr)
WO (1) WO1999039709A1 (tr)
ZA (1) ZA99918B (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO129043B (tr) * 1968-02-16 1974-02-18 Fujisawa Pharmaceutical Co
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja) * 1981-09-24 1983-03-28 Fujisawa Pharmaceut Co Ltd 血清尿酸値低下剤
JPH07116039B2 (ja) * 1988-01-11 1995-12-13 オール薬品工業株式会社 安定な塩酸トリメトキノール内用液剤
AR245888A1 (es) * 1989-01-23 1994-03-30 Merrell Pharma Inc Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
EP0733368A1 (en) * 1995-03-24 1996-09-25 Eli Lilly And Company Granule fomulation for olanzapine
GB9526264D0 (en) * 1995-12-21 1996-02-21 Knoll Ag Medical treatment
JPH09286723A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤

Also Published As

Publication number Publication date
GB9802617D0 (en) 1998-04-01
HK1033088A1 (en) 2001-08-17
US6239165B1 (en) 2001-05-29
HRP20000579A2 (en) 2001-04-30
ATE227988T1 (de) 2002-12-15
AR018062A1 (es) 2001-10-31
SK11472000A3 (sk) 2001-08-06
DE69904021D1 (de) 2003-01-02
DE69904021T2 (de) 2003-04-30
AU2720099A (en) 1999-08-23
WO1999039709A1 (en) 1999-08-12
EP1054666A1 (en) 2000-11-29
CA2320475A1 (en) 1999-08-12
CZ20002846A3 (cs) 2000-12-13
PL342213A1 (en) 2001-05-21
JP2002502818A (ja) 2002-01-29
PT1054666E (pt) 2003-03-31
HUP0100769A3 (en) 2002-04-29
BG104682A (bg) 2001-05-31
CZ291975B6 (cs) 2003-06-18
CO4970815A1 (es) 2000-11-07
ES2188135T3 (es) 2003-06-16
HUP0100769A2 (hu) 2001-12-28
EP1054666B1 (en) 2002-11-20
KR20010040717A (ko) 2001-05-15
BR9907644A (pt) 2000-11-14
DK1054666T3 (da) 2003-03-17
ZA99918B (en) 2000-08-07

Similar Documents

Publication Publication Date Title
IL150986A0 (en) 1,2,3,4,- tetrahydroisoquinoline derivatives
DE60305724D1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
CA2277877A1 (en) Nitric oxide synthase inhibitors
MXPA03004780A (es) Nuevas sulfamidas.
CA2435276A1 (en) Syntactic deformable foam compositions and methods for making
CA2370692A1 (en) Antitumor derivative of double dicarboxylic acid diaminoplatin complex, process for the preparing thereof, the pharmaceutical composition containing the same and application of the derivative
WO2002076979A8 (en) 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
WO2002048148A3 (en) Pyrazolopyridine derivatives
WO2004082581A3 (fr) Application a titre de medicaments de derives de cholest-4-en-3- one, compositions pharmaceutiques les renfermant et nouveaux derives
CA2387193A1 (en) Compositions for electroporation
WO2002024697A1 (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
WO2002096372A3 (en) Topical composition comprising an activated, trans-structured cosmetic bonding agent
CA2359491A1 (en) Mixture of plant treatment compositions with waxes, their preparation, and their use
NO20052520L (no) Nye sulfamider
TR200002288T2 (tr) Zotepin içeren sıvı farmasötik formülasyon
WO2002072058A3 (en) Topical composition comprising a functionalized acid anhydride-based cosmetic bonding agent
CN101189967B (zh) 杀虫剂组合物
WO2002072060A3 (en) Topical composition comprising a three membered cyclic compound-based cosmetic bonding agent
EP1270572A4 (en) CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCTION AND USE
WO2002072056A3 (en) Topical composition comprising a diazonium salt-based cosmetic bonding agent
TW200503749A (en) Preserved and stable compositions containing peptide copper complexes and methods related thereto
TW200724603A (en) Polyalkoxylate-comprising solid formulations, processes for their preparation and their use
MXPA02006250A (es) Derivados de butino diol.
DE60108509D1 (de) Härtbare zusammensetzungen,die polysäure(n) und polyol(e) enthalten
WO2003007922A3 (de) Arzneimittelformulierung enthaltend einen ltb4 antagonisten